In early 2022, Cleveland Clinic formally adopted the recently retooled race-free estimated glomerular filtration rate (eGFR) formula for consistent use across the enterprise.
It’s been three years since the announcement of the American Kidney Health executive order, which defined a framework for policies aimed to transform prevention, diagnosis, and treatment of kidney disease. Here’s a look at what we’re doing to achieve these goals.
The National Kidney Foundation and the American Society of Nephrology Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases released its final report outlining a new race-free approach to diagnose kidney disease. Crystal Gadegbeku, MD, Cleveland Clinic’s Chair of Kidney Medicine and a member of the task force, discusses their approach.
Nephrologists talk about the need for disruption in kidney medicine and two clinical trials poised to set the stage for more individualized care.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Urology and nephrology, both traditionally male-dominated specialties, are attracting more women. Crystal Gadegbeku, MD, Chair of Cleveland Clinic’s Department of Kidney Medicine, comments on the importance of diversity in medicine.
Updated recommendations in managing blood pressure in chronic kidney disease, the first in nearly a decade, have sparked discussion about how this translates to clinical practice.
Cleveland Clinic announces new Department Chair of Nephrology, Crystal Gadegbeku, MD.